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Abstract 
Fluoroquinolones (FQs) are used for therapy and prophylaxis of human and animal 
diseases and they are also used as growth promoters of animals.  
The usage of antibiotic is in connection with development of antibiotic resistance 
among bacterial populations. Since swine production industry is considered to be a 
relevant source of antibiotic resistant bacteria, measures to control the use of 
antimicrobial agents in animal husbandry have been adopted in recent years (1). 
The presence of FQs in wastewater from swine farms can introduce antibiotics in 
surface waters through agricultural runoff. FQs are rather resistant to microbial 
degradation and these compounds may be persisting within environmental waters 
because of their sorption properties, favouring the accumulation in sewage sludge, 
manure and soil (2). 
To trace the sources and ways of contamination, and evaluate the environmental 
impact of an outdoor swine production system, the occurrence norfloxacin (NOR), 
ciprofloxacin (CIP) and enrofloxacin (ENRO) residues were evaluated in wastewater 
and surface water samples. A LC-FD method based on the application of monolithic 
column (Chromolith Performance RP-18e (100 x 4.6 mm) successfully developed in 
previous studies (3,4,5) was applied. FQs were isocratically eluted using a mobile 
phase consisting of 0.025 M Phosphoric acid solution at pH 3.0 with 
tetrabutylamonium and methanol (90:10, v/v), at a flow rate of 2.2 mL/min, at an 
excitation and emission wavelengths of 278 and 450 nm respectively.  
The limits of quantification (LQs) of these FQs, expressed as the lowest tested level 
with acceptable RSD was 25 ng/l. Recoveries yield of spiked samples ranged from 
66.4% to 114%. Within-day accuracy and precision (expressed as RSD) data 
obtained were under 17%. 
The method was successfully applied for determination of NOR, CIP and ENRO in 
water samples, collected from an intensive piggery, in Portugal.  
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1. INTRODUCTION 
The knowledge of concentration of pharmaceuticals in water is very important. The 
concern of these compounds as environmental contaminants is based in the fact that 
they are developed with the intention of performing a biological effect and they often 
have the same type of psycho- chemical behaviour as other harmful xenobiotics 
(persistence in order to avoid the substance to be inactive before having a curing 
effect, and lipophilicity in order to be able to pass membranes) (6).  
The primary source of antibiotics in the environment is the excretion of incompletely 
metabolized antibiotics by humans and animals.  
With increasing usage of antibiotics increase also their occurrence in environment 
and their potential risk. 
The impact may be on any level of the biological hierarchy: cells ± organs ± 
organisms ± population ± ecosystems ± the ecosphere (7). 
Fluoroquinolone antibiotics (FQs) were shown to display high genotoxicity at 
concentrations detected in hospital effluent (3000 to 87,000 ng /L). Genotoxic 
substances are often mutagenic and carcinogenic and are, therefore, potentially 
suspect in the development of antibiotic resistant organisms (8). 
FQs are probably among the most important class of synthetic antibiotics in human 
and veterinary medicines worldwide (9).They are widely used in the treatment of a 
wide variety of diseases. They are effective against Gram- negative bacteria and 
Gram- positive bacteria as well. 
The aim of this work was to determine the concentration of FQs antibiotics, namely 
norfloxacin, ciprofloxacin and enrofloxacin in wastewater and surface water from an 
intensive piggery, in Portugal.  
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2. THEORETICAL PART 
 
2.1 USAGE OF ANTIBIOTICS 
Thousands of tons of pharmaceuticals are used yearly with different purposes such 
as the prevention, diagnosis, cure and mitigation of diseases or just to improve the 
state of health not only in humans but also in animals such as cattle, swine, poultry, 
and fish (10, 11). Antimicrobial agents are administered to livestock at therapeutic 
doses or to prevent illness (prophylaxis) at much lower doses (subtherapeutic). 
Antimicrobial agents are also used as feed additives to increase the rate of growth 
and to improve feed efficiency (12). 
 
2.2 SOURCE OF ANTIBIOTICS IN ENVIRONMENT 
Most of the compounds used in medicine are only partially metabolized by patients 
and are then discharged into the hospital sewage system or directly into municipal 
waste water if used at home (13). 
About 25% to 75% of compounds leaving the organisms unaltered via feces or urine 
(14). 
Metabolism may result in chemicals that are either more or less biologically active 
than the form in which they were consumed (15). 
Along with excreta, they flow with municipal waste water to the sewage treatment 
plant (STP) (7). 
Residential (private residences, dormitories, hotels, and residential care facilities) 
and commercial facilities (including hospitals) are also known contributors of 
antibiotics to municipal wastewater (8). 
After the administration of veterinary medicinal products in livestock husbandry, 
parent compounds and metabolites are excreted by production animals via urine and 
feces. (16) 
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Veterinary medicinal products that are not degraded during manure storage and they 
are applied to farmland or grassland soils as organic fertilizers. Therefore, they can 
enter aquatic and soil environments via this entry route. This fact is namely 
considered relevant by the authorization procedure of veterinary medicinal products 
(16).  
Numerous studies on fate and behaviour of veterinary medicinal products in pig 
manures clearly demonstrated possible effects of manure application to fields on the 
fate of veterinary medicinal products (16). These antibiotics may either end up in soil 
or sediment or in ground water (13). 
Antimicrobial agents are also used to treat infections in intensive fish farming where 
they are added directly into the water, resulting in high local concentrations in the 
water compartment and abutting sediments. (13) 
Some antibiotics such as streptomycins are used in fruit growing, others in bee-
keeping (13).  
Treatment of raw wastewater (which includes a mix of domestic sewage, industrial 
wastewater, and stormwater runoff, depending on the wastewater treatment plants 
(WWTPs) may remove a proportion of these compounds, but there is the potential for 
residues of antimicrobials to be released in treated effluent into the aquatic 
environment (11). 
Nevertheless, there is a lack of the fate of veterinary medicinal products 
environmental compartment until today. (17) 
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Fig. 1. Scheme showing possible sources and pathways for the occurrence of 
pharmaceutical residues in the aquatic environment.(19) 
 
2.3 FATE OF ANTIBIOTICS IN ENVIRONMENT 
 
On release via urine and faeces into the environment, antibiotics disperse through a 
variety of transport mechanisms. The introduction of drugs into the environment is a 
function of the combination of several factors. A number of physical and chemical 
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processes are responsible for the antibiotics moving through the feedlot or the open 
pasture into the environment. Sorption, leaching and degradation are the three 
important processes in the soil–water systems. These processes are driven by the 
physico- chemical properties of the antibiotics, such as their molecular structure, 
size, shape, solubility and hydrophobicity, dissociation constants and also by the 
quantity manufactured, the dosage (amount, frequency and duration), the excretion 
efficiency of parent compound and metabolites, the adsorption/desorption on soil 
capability and the metabolic decomposition in sewage treatment. Before discussing 
their fate and transport in the environment, the basic chemistry of these compounds 
should be understood because may help determine whether a compound is likely to 
concentrate in the aquatic, terrestrial, or atmospheric environment (20, 21) 
Concentration of pharmaceutical in the environment, their temporary evolution and 
their possible synergic and antagonist effects depend also on geographical area and 
climate conditions (22). 
The drugs used by humans will be discharged to the sewer systems together with the 
urine and faeces and enter the STP. The possible fate of drugs in the STP may be 
divided as follows: 
(i) The drug or metabolites of the parent drug is mineralized by micro-organisms to 
carbon dioxide and water, e.g., aspirin. 
(ii) The drug or metabolites of the parent drug can persist in the STP. It depends 
mainly on the lipophilicity or other binding possibilities e.g. ionic bindings, a part of 
the substance will be retained in the sludge. If the sludge is used as soil conditioner 
drugs may be dispersed on agricultural fields. Again the fate of the drugs depends on 
the lipophilicity or other ability of binding to sludge or soil.  
Drug molecules often have many functional groups e.g., carboxylic acids, aldehydes 
and amines, which makes the binding capacities of the molecules to solids 
dependent on pH or other constituents (e.g., complexation) in the solids matrix.  
Drugs that are mobile in the soil may be a threat to the ground water or leach to a 
nearby stream. Depending on the ability of the drug to bind solids either organisms in 
the terrestrial ecosystem or aquatic ecosystem may be exposed. 
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(iii) The drug or metabolites of the parent drug is persistent and at the same time very 
polar and nonbinding to solids. The substance will thus not be retained neither 
degraded in the STP and therefore easily reach the aquatic environment, and may 
affect the aquatic organisms (7). 
An unknown portion of drugs marketed for human treatment ends in the sewer 
system as surplus medical substances (7). 
 
Most of the drugs used for veterinary purposes will end up in manure which is 
conserved in tank systems before being dispersed on fields. As previously explained 
the mobility of the drugs or drug metabolites in the soil system predicts if the drug will 
threat the ground water, affect the terrestrial organisms, or the aquatic organisms, 
due to leaching from fields (7). 
If the drugs are applied to foraging animals drug or drug metabolites will be urinated 
or defecated directly on the field and that way may give much higher local 
environmental loadings of drugs (7). 
Drugs used as a feed additive in fish farming will be discharged directly to the 
receiving water as parent compound, because a large portion of the applied 
medicated feed is not eaten by the fish. A local water treatment plant is often treating 
the water from aquaculture before going to the aquatic environment. The sludge from 
these treatment plants are also used as soil conditioner so drugs used in fish farming 
may also end on agricultural soil and undergo the same fate as previously described 
for the growth promoters and therapeutically used drugs (7). 
Probably, it was assumed that they occur in sufficiently low concentrations to be 
harmless for the environment independent on their biological activity. It may be the 
case if all drugs discharged to the environment would be diluted in the total 
environment. But several drugs are discharged locally, for instance antibiotics in 
manure which is spread on a few hectares of agricultural land, or hospital waste 
water discharged via a relatively small treatment plant to a local stream or lake (7). 
The amount of pharmaceuticals and their bioactive metabolites being introduced into 
the environment is probably low. However, their continual input into the environment 
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may lead to a high, long-term concentration and promote unnoticed adverse effects 
on aquatic and terrestrial organisms. Effects can accumulate so slowly that changes 
remain undetected until they become irreversible (20). 
Gathering baseline information about the existence and extent of these 
environmental pollutants is an essential first step toward understanding the 
environmental impact or human health (12). 
Recent evidence suggests that the interaction between bacterial organisms and 
antimicrobial agents in the environment may contribute to the development of 
antimicrobial-resistant bacterial strains, with groundwater serving as a potential 
source of antimicrobial-resistant pathogens in the human food chain (12). 
Recent analytical studies show that some pharmaceuticals are poorly removed in 
STP and are consequently detectable in surface water (rivers, lakes, seas) in the 
ng/L up to the µg/L range. STPs might therefore be the important point source of 
contamination, but for the majority of pharmaceuticals little information is available on 
their behaviour and ultimate fate in STPs and in the receiving surface water (23). 
Thus, the antibiotics may accumulate and reach concentrations in the Minimal 
inhibitory concentration (MIC) range. If they are still effective after sorption, resistant 
bacteria may be selected by antibiotic substances due to their application in animals, 
their use as growth promoters and in soil. (13) 
2.3.1 Occurrence in Sediments and Sludge 
The persistence of a drug in a sediment or soil depends mostly on its photostability, 
binding and adsorption capability, degradation rate, and leaching into water. In 
addition, the rate of sedimentation conditions the halflife of the chemical.  
Strongly sorbing pharmaceuticals accumulate in the soil or sediment more than 
highly mobile pharmaceuticals, which tend to leach to the groundwater and be 
transported with the groundwater, drainage water, and surface run-off to surface 
waters. (24)  
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The ratio between the concentration of the compound in the sorbent and in the water 
at equilibrium is called sorption coefficient (Kd,solid ). This coefficient, however, is hard 
to calculate under the multiple and variable conditions of each particular 
environment. In addition, the Kd,solid of many neutral hydrophobic organic chemicals 
has been shown to vary depending on the organic carbon content of the sorbent. For 
such compounds, use of the so called organic carbon-normalized sorption coefficient 
(Koc) is recommended. Another aspect that favors the use of Koc as a measure of the 
sorption in environmental risk assessment is the strong correlation existing between 
this coefficient and the octanol-water partition coefficient (Kow) an easily obtained 
physicochemical property from which the Koc can be easily calculated. Quite a 
number of different mechanisms are involved in drug sorption, the most important 
being sorption to organic matter, surface adsorption to mineral constituents, ion 
exchange, complex formation with metal ions (such as Ca 2+, Mg 2+, Fe 3+ or Al 3+), 
and H-bonding (24). 
The main processes of substance elimination in the environment, especially in waste 
water, sediments, and soil are due to bacteria. The concentration of antibiotics may 
be much higher if the active compounds are persistent and accumulate. In these 
cases, the role of antimicrobial concentration could be different from that in water. It 
is not known how strongly the antibiotics are sorbed and under what circumstances 
they are still available and active after sorption. (13) 
Fluoroquinolones (FQs) are sorbed by organic matter. Therefore, they can 
accumulate. It is not yet known to what degree and under what circumstances the 
compounds are effective after sorption or whether they are released and may 
contribute to resistance. Antimicrobials may have qualitative and quantitative effects 
upon the resident microbial community of the sediments. (13) 
 
3.3.2 Occurrence in drinking water 
Although their concentration are extremely low (ranging from hundreds of µg/L to less 
than ng/L), we currently do not know what impacts long- term exposure to these 
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compounds at low levels will have on people consuming contaminated drinking 
water. The main areas of interest focus on PPCPs role in endocrine disruption and 
antibiotic resistance. (15) 
The drinking-water-treatment facility utilizes a conventional treatment process that 
consists of the following sequence of physical and chemical treatments:  
I. Raw-water screening – the movement of raw water past a stationary bar rack and 
two travelling screens to remove coarse debris.  
II. The addition of powdered activated carbon to remove taste- and odor causing 
compounds as well as organic chemicals.  
III. The addition of sulphuric acid or caustic soda for pH control.  
IV. Coagulation – the addition of coagulant salts and polymers to destabilize colloidal 
particles and facilitate their flocculation with other suspended particles.  
V. Primary disinfection – the addition of Na hypochlorite to inactivate pathogenic 
microorganisms.  
VI. Flocculation – the agitation of coagulated water to promote the aggregation of 
suspended materials.  
VII. Sedimentation – the stilling of flocculated water to promote the settling of 
suspended solids and floccules.  
VIII. Filtration – the movement of water through tanks that contain sand and either 
bituminous granular activated carbon (GAC), lignite GAC, or anthracite to retain 
remaining fine solids and bacteria.  
IX. Secondary disinfection – the addition of Na hypochlorite to maintain a chlorine 
residual in the distribution system.  
X. The addition of caustic soda to adjust the pH at 7.8 to 8.2 for corrosion control 
(25). 
 
2.4 POTENTIAL EFFECT OF ANTIBIOTICS IN ENVIRONMENT 
Antibiotics can cause adverse effects on ecological systems and also on humans, 
e.g. allergic reactions. However, the main worry arises from the potential generation 
and/or spreading of new strains of resistant bacteria. 
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Concentrations below therapeutic levels may play a role in the selection of resistance 
and its genetic transfer in certain bacteria. Exposure of bacteria to sub-therapeutic 
antimicrobial concentrations is thought to increase the speed at which resistant 
strains of bacteria are selected. Resistance can be transferred to other bacteria living 
in other environments such as ground water or drinking water. In general, knowledge 
of sub-inhibitory concentrations and their effects against environmental bacteria is 
poor, especially with respect to resistance (26). 
2.4.1. Bacterial Resistance 
The resistance is a description of the relative insusceptibility of a microorganism to a 
particular treatment under a particular set of conditions. For bacterial resistance it is 
usually quantified as the minimum concentration required to assert a definable effect 
(e.g. growth inhibition) on a population of cells. Wherever there is a change in 
susceptibility that renders an agent ineffective against a certain organism, this 
organism is referred to as resistant. Many organisms have always been insensitive to 
and are thereby intrinsically resistant to a particular agent by nature of their 
physiology or biochemistry. Susceptible organisms can become insensitive by 
mutation or by incorporation of the genetic information which encodes the resistance 
(13). 
The bacterial resistance is a natural part of the regulatory factors in any ecosystem.  
Bacteria have presented on the Earth for more than 3.8 milliards years and they have 
to adapt to environmental influences all the time. Therefore it is obvious that genes 
coding for resistance have existed as long as microbes. The increased use of 
antibiotics during the last five decades has caused a genetic selection of more 
harmful bacteria. The genetic pool of micro-organisms in nature has changed 
significantly, simply due to our increasing production and consumption of antibiotics 
(7, 18). 
Antibiotic-resistant bacteria were detected in drinking water as early as the 1980s 
and later in the 1990s. Authors found that resistant bacteria identified using classical 
microbiological methods, i.e. standard plate counting, occurred within the distribution 
network of drinking water supply systems. They concluded that the treatment of raw 
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water and its subsequent distribution selects for antibiotic-resistant bacteria. In 
agreement with these data, increased phenotypic resistance rates were also 
detected at the drinking water sampling points in the study by Schwartz et al. (13). 
For example, FQs usage in poultry husbandry have promoted the evolution of 
fluoroquinolone- resistant Campylobacter jejuni (Gaunt and Piddock, 1996), an 
important human pathogen. Exposure to FQs can result in a high fluoroquinolone 
MIC, for example of 4 mg/L for C. jejuni. Development of resistance to FQs typically 
occurs within 2 years of their widespread application in veterinary medicine (14). 
2.4.2. Direct toxicity to microorganism 
 Apart from the issue of resistance, it has to be kept in mind that bacteria form one of 
the most important groups of organisms in soil and in other environmental 
compartments as well as in natural or technical sewage treatment. Residues of 
antimicrobials may also be directly toxic to microorganisms. Without bacteria, water 
would not be clarified. Bacteria are essential for the closing of nutrient and 
geochemical cycles such as the carbon, nitrogen, sulphur and phosphorous cycle. 
Without bacteria, soil would not be fertile and organic matter such as straw or leaves 
would accumulate within a short time. In soil, naturally occurring antibiotics from 
bacteria and fungi amongst others control the dynamics of bacterial populations. In 
contrast to these, most of the compounds used nowadays are semi-synthetic or 
synthetic. They are often much more stable and are not biodegradable by bacteria. 
They may therefore persist in the environment. Furthermore, they often have a 
different, e.g. broader, activity spectrum. (11, 13). 
2.4.3. Detection of negative effects 
Detection of these negative effects in the environment is difficult; although in vivo and 
in vitro laboratory tests generally show that the toxic effects of these compounds are 
not seen at the low levels currently detected in the environment, the possibility of 
variations in sensitivity, chronic exposure, and mixture effects such as concentration 
addition and synergism mean that other negative effects cannot be ruled out (27). 
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2.5 PROPERTIES OF FQs 
 
Antimicrobially active compounds make up a large group of pharmaceuticals, which 
are widely used for the abatement of bacterial infections with humans and also with 
animals. Therefore, they are some of the most prescribed pharmaceuticals. In the 
European Union (EU) (including Switzerland) in 1997 the total amount of antibiotics 
used was 12 752 t. 7 659 t were used in human therapy and 5 093 t were applied in 
the veterinary sector, which is subdivided in: 
1) antibiotics for therapeutic use with animals (in order to defeat or prevent an 
infection),  
2) antibiotics, which are used as feed additives to accelerate growth (growth 
promoters). 
For the first purpose in 1997 3 494 t were used, and for the second (i.e., as growth 
promoters), 1 599 t. In the last years a couple of substances has been prohibited by 
EU legislation for their use as growth promoters, due to the assumption that an 
increasing medication with antibiotics in subtherapeutic dosage can cause resistance 
in bacteria, which makes therapy more difficult, because less substances are able to 
cure an infection. Perhaps due to this regulation, the amount of antibiotics used as 
feed additives has lowered to its half, to 786 t in 1999,while the amount for human 
and also for animal therapy increased by 12%, so that in 1999 an overall mass of 13 
216 t of antibiotics has been used (28). 
2.5.1. Usage 
Qs and FQs represent a highly potent group of modern antibiotics. They are 
nowadays broadly used in the treatment of a wide variety of diseases since they are 
not only more effective against Gram-negative bacteria but also moderately active 
against Gram-positive bacteria. They are used in the treatment of a great variety of 
respiratory diseases and enteric bacterial infections, treatment of Gram-negative 
urinary tract infections in humans and animals. 
Quinolones are also used to treat livestock and fish in the aquaculture industry and 
used at sub-therapeutic levels to promote growth for animals.  
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FQs are antibacterial agents widely used for various infections because of 
characteristic of their broad activity spectrum and good oral absorption, good 
tolerance with less resistance. Compared with other drugs, Qs have a rapid 
bactericidal effect against most susceptible organisms, that is very important for 
patients who are seriously ill or for patients with defective or impaired immune 
system. In addition, they penetrate into tissues and mammalian cells extremely well 
which enables their widespread use in clinical medicine.  Generally, FQs are 
prescribed 300–600 mg/day to the patient for therapeutic treatment.  
The FQs administered to humans or animals are almost excreted as unchanged 
compounds in urine, and are mainly effluent from WWTP, but these compounds are 
not carried out monitoring on WWTP (11, 29, 30, 31, 32). 
2.5.2.Mechanism of activity 
Their activity is based on inhibition of DNA gyrase (topoisomerase II), a bacterial 
enzyme involved in DNA replication, recombination and repair, leading to bacterial 
cell damage (32). 
2.5.3. Chemical structure 
FQs are piperazinyl derivates of the quinolone nalidixic acid (NAL) and represent the 
second generation of this family of antibiotics.  
Quinolones (Qs) are originated from antimalarial agent chlorquine, but NAL, the first 
generation quinolone antibiotics synthesised in 1962, had only modest antibacterial 
activity against gram-negative species and showed poor oral absorption. Introduction 
of a piperazinyl side chain at position 7 improved the activity against gram-negative 
bacteria and increased the penetration into bacterial cell wall. Fluorination at position 
6, which was called fluoroquinolone antibiotics, increased their activity against gram-
positive bacteria. Modification of molecular structure by substitution of both 
piperazinyl group and fluorine atom improved their efficiency. NOR, Enofloxacin 
(ENO), Fleroxacin (FLE), CIP and Ofloxacin (OFL) had broad antibacterial spectrum 
extending to most gram-positive species but their effect is still inadequate to treat 
respiratory infections. Recently developed newer generation Qs are trying to solve 
these problems by enhancing activity against gram-positive or anaerobic bacteria. 
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They are also active against atypical organisms like mycoplasma, chlamydiae, 
legionella or some mycobacteria (29, 32). 
2.5.4. Physico- chemical properties 
I. pH dependence 
All compounds contain the keto oxygen at C-4 and carboxylic acid side chain at C-3, 
both of which have now been found to be essential to activity.  
Due to carboxyl group and amine groups, the acid–base behaviour will be influenced 
by the physicochemical properties of solvent. (32) 
Also, the antibacterial activity is pH-dependent, because these drugs act by inhibition 
of bacterial DNA gyrase, a process that depends upon both the pH and concentration 
of the acid. To this effect, the behaviour of Qs in vivo is significantly influenced by 
their degree of ionization. It has often been shown that the presence of charged 
groups is necessary for biological activity and solubility. However, the unionized form 
has a more favourable partition coefficient toward no aqueous solvents. Therefore, 
knowledge of the physico- chemical properties of these drugs such as dissociation 
constants may be essential for practical purposes and for the interpretation of 
structure–activity relationships. (32) 
Therefore, Qs having different structures and substituents exhibit different 
antibacterial responses in various environments. Especially, the two groups of drugs, 
OFL, NOR, ENO etc., and NAL, Flumequine (FLU), Oxolinic acid (OXO) etc., show 
completely different antibacterial responses and chemical properties as the 
physicochemical properties of solvents are changed. These differences are governed 
by the presence of piperazinyl group at 7-carbon atom. With OFL and NOR, a pH 
increment from 5.6 to 8.3, which is the pH range that occurs in urine, progressively 
increases their activity in nutrient agar. On the other hand, NAL, FLU and OXO 
become more active in nutrient agar as the pH falls. (32) 
Between Qs and some divalent cations 1:1 complexes are formed by ion–dipole 
interaction using the 4-keto oxygen and the ionised 3-carboxylic acid group. So when 
Mg2+ is added to an achievable urinary concentration (5.6 mM), the activity of these 
drugs is reduced at virtually every pH tested, but the antagonistic action of Mg2+ on 
these two groups of drugs, with or without piperazinyl group, does not exhibit similar 
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pH dependence. These observations suggest that there is a major difference 
between the two groups of drugs, with respect either to their mode of action, or to 
their mechanism of penetration into bacteria. (32). 
II. Complex formation 
The complex formation between Qs and divalent cations plays an important 
biological role. The ability of these drugs to interact with some cellular components is 
mediated by this complexation. Several studies have shown that a DNA gyrase 
cannot bind quinolones in the absence of DNA and the amount of Qs bound to DNA 
is modulated by the Mg2+ concentration. The photocarcinogenic potential of some Qs 
could be related to their ability to interact with DNA. (32) 
III. Resistance 
Some studies have demonstrated that bacterial resistance against FQs in the 
hospital wastewater is higher than that in the sewage treatment plant wastewater. 
These antibiotics are rather resistant to microbial degradation and these compounds 
may be persisting within environmental waters because of their strong sorption 
properties. On the other hand, degradation of antibiotics, including photolysis and 
chemical oxidation may be significant on their environmental ecosystem. Effluence of 
FQs into the environmental waters occurs mainly as the parent compounds and as a 
consequence of inadequate treatment of human and animal excreta. It is 
apprehensive that bacteria exposed with antibiotics in environmental waters may 
acquire resistances against antibiotics (30). 
 
IV. Photosensititivity 
It is reported that these drugs are able to induce photosensitivity reaction in human 
skin by sunlight. This effect will occur in any subject with sufficient cutaneous 
photosensitiser exposed to enough irradiation of appropriate wavelength, but the 
mechanism remains still unknown. (32). 
Drug-induced photosensitivity can be divided into phototoxicity and photoallergy. 
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(i) Phototoxicity is an adverse cutaneous response to the combined actions of a 
chemical agent such as a drug and a physical agent such as UV radiation. The Qs 
are one of typical photosensitiser. Phototoxicity owing to these antibiotics was 
caused by the reactive oxygen species (ROS). Oxygen-dependant release of ROS 
induces phototoxic damage on cell surface, DNA and lysosome. In an in vivo mouse 
experiment, phototoxicity increased UVA-induced edema, sunburn, cell formation 
and local suppression of immune response. Increment of prostaglandin E2 
production and depletion of Langerhans cells owing to phototoxicity would be 
responsible for this local immune suppression. Clinically, phototoxicity shows 
features of exaggerated sunburn, and long-term intake of a photosensitiser may 
induce cataract of ocular lens or photo-aging of skin. Phototoxicity also may increase 
skin cancers like squamous cell carcinoma and malignant melanoma.  
Lomefloxacin (LOM) or FLE, which have another fluorine atom at C-8, exhibited 
increased photocarcinogenic potentials. Most quinolones show phototoxicity in 
various in vitro methods, which examine fluorescence or phototoxic killing of 
organisms or phototoxic destruction of cells, and in vivo methods, which measure 
swellings or erythema (32) 
Substitution of position 8 with halogens increases phototoxicity, but substitution of 
this position with methoxy group reduces phototoxicity (32). 
 
(ii) Photoallergy shows features of allergic contact dermatitis like poison ivy in 
exposed areas. Without UV radiation, they are usually inert. In the presence of UV 
light, Qs are activated to bind with skin protein, which becomes complete antigen and 
induces allergic dermatitis. (32) 
 
V. Spectroscopic properties 
To study the spectroscopic properties of Qs, OFL, NOR and FLU were selected as a 
model compounds. In aqueous solution, the absorption spectrum of OFL and NOR 
contain two major bands. In organic solvents, the strong band shifts toward the long 
wavelength side by ~15 nm. In aqueous solution, the emission spectra of OFL and 
NOR are strong, broad structureless band with large Stokes’ shift. In organic 
solvents, the emission intensities of OFL and NOR are very weak, the lifetimes 
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become long and another small band appears in short wavelength region (350–400 
nm). Moreover, the red shift of main emission band is observed in CH3OH and 
CH3CN compared with that in aqueous solution. The absorption and emission 
spectra of OFL and NOR in organic solvents have roughly mirror image relationships, 
especially for OFL. Such observations indicate that the geometry change upon 
excitation is small in organic solvents. For all three molecules, the changes of dipole 
moment upon excitation are small in gas phase. In aqueous phase, this dipole 
moment changes of OFL and NOR are very large. Because the internal conversion 
rate of S1 → S0 for OFL and NOR will be very fast in organic solvents owing to the 
similar geometrical structures and dipole moments between these states, the 
fluorescence quantum yield becomes very low. Furthermore, the lifetimes of OFL and 
NOR in organic solvent are longer than those in water. (32). 
The OFL and NOR have two electron releasing nitrogen atoms; the one is the 
nitrogen at position 1 and the other is the nitrogen of the piperazinyl group attached 
directly to the C-7 atom (N-16). The keto oxygen of OFL and NOR will serve as a 
good electron acceptor. Having both electron donors and acceptor, OFL and NOR 
may become one of the good donor– acceptor conjugated molecules (32). 
VI. Biodegradability 
The Closed bottle test (CBT) is recommended as a first, simple test for the 
assessment of the biodegradability of organic compounds (Nyholm, 1991; OECD, 
1992). The CBT was performed according to test guidelines (OECD, 1992) in the 
dark at room temperature (20. 1°C), as described elsewhere in detail (Kummerer et 
al., 1996a). The standard test period of the CBT is 28 days, In the toxicity controls of 
the tests with the FQs CIP and OFLO, an inhibition of the biodegradation was 
observed within the first days of the test. The inhibition disappeared after 8 and 11 
days, respectively. The CIP concentration in the test vessels was analysed by HPLC. 
Within the analytical error no elimination of CIP was found (data not shown). A 
prolongation of the test period did not influence the results (33). 
  Fluoroquinolone carboxylic acids are photodegradable in aqueous solution. In the 
case of entering the aquatic environment via sewage water, the photo-degradation 
route is only of minor importance. Only if the substances are not eliminated in the 
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STP a possible photo-degradation in surface water must be taken into account, if 
they are not adsorbed to sediments (33). 
 
2.6. ENROFLOXACIN 
 
Fig. 2. Enrofloxacin 
1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-Fluoro-1,4-Dihydro-4-Oxo-3-
Quinolonecarboxylic Acid 
Enrofloxacin (ENRO) is used exclusively in veterinary medicine. It is available in 
several oral and parenteral formulations and is effective in controlling a wide range of 
bacteria. (34) 
It is a lipophilic and amphoteric antibiotic which is extensively distributed from the 
bloodstream into different tissues including those colonised by pathogenic bacterial 
strains. ENRO undergoes deethylation to CIP (the active compound used in human 
medicine). ENRO and its metabolite CIP are effective against microorganisms which 
are resistant to other antimicrobial agents used for the treatment of endometritis, 
such as aminoglycosides, tetracyclines, macrolides and β-lactams (34). Endometritis 
is uterine infection due to bacteria ant it is one of the most common causes of 
infertility in mares. In one study, one third of all barren mares were found to be 
infected. (35) 
Chronic infectious endometritis and venereal diseases are caused mainly by 
Streptococcus zooepidemicus, Escherichia coli, Klebsiella pneumoniae, 
Pseudomona aeruginosa and Taylorella equigenitalis.  
 Despite its obvious potential, ENRO is not currently recommended for use in horses. 
One reason for this is the concern raised by some authors over the possible 
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association between intravenous and/or oral ENRO administration and arthropathy in 
young horses.  
The pharmacokinetic behaviour of ENRO in horses has not been fully characterized 
although several recent studies have been undertaken in adult animals and foals with 
the aim of optimizing the use of ENRO in the equine (10, 34). 
 
2.7 CIPROFLOXACIN 
 
 
Fig.3. Ciprofloxacin 
1-cyclopropyl- 6-fluoro- 4-oxo- 7-piperazin- 1-yl- quinoline- 3-carboxylic acid 
2.7.1 Distribution 
The binding of CIP to serum proteins is 20 to 40% which is not likely to be high 
enough to cause significant protein binding interactions with other drugs. 
After oral administration, CIP is widely distributed throughout the body. Tissue 
concentrations often exceed serum concentrations in both men and women, 
particularly in genital tissue including the prostate. CIP is present in active form in the 
saliva, nasal and bronchial secretions, mucosa of the sinuses, sputum, skin blister 
fluid, lymph, peritoneal fluid, bile, and prostatic secretions. CIP has also been 
detected in lung, skin, fat, muscle, cartilage, and bone. The drug diffuses into the 
cerebrospinal fluid (CSF), however, CSF concentrations are generally less than 10% 
of peak serum concentrations. Low levels of the drug have been detected in the 
aqueous and vitreous humors of the eye (36). 
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2.7.2 Metabolism 
Four metabolites (desethylenciprofloxacin, sulphociprofloxacin, oxociprofloxacin and 
formylciprofloxacin) have been identified in human urine which together account for 
approximately 15% of an oral dose. The metabolites have antimicrobial activity, but 
are less active than unchanged CIP. 
CIP is an inhibitor of human cytochrome P450 1A2 (CYP1A2) mediated metabolism. 
Coadministration of CIP with other drugs primarily metabolized by CYP1A2 results in 
increased plasma concentrations of these drugs and could lead to clinically 
significant adverse events of the coadministered drug (36). 
2.7.3 Excretion 
The serum elimination half-life in subjects with normal renal function is approximately 
4 hours. Approximately 40 to 50% of an orally administered dose is excreted in the 
urine as unchanged drug. After a 250 mg oral dose, urine concentrations of CIP 
usually exceed 200 μg/mL during the first two hours and are approximately 30 μg/mL 
at 8 to 12 hours after dosing. The urinary excretion of CIP is virtually complete within 
24 hours after dosing. The renal clearance of CIP, which is approximately 300 
mL/minute, exceeds the normal glomerular filtration rate of 120 mL/minute. Thus, 
active tubular secretion would seem to play a significant role in its elimination. Co-
administration of probenecid with CIP results in about a 50% reduction in the CIP 
renal clearance and a 50% increase in its concentration in the systemic circulation. 
Although bile concentrations of CIP are several fold higher than serum 
concentrations after oral dosing, only a small amount of the dose administered is 
recovered from the bile as unchanged drug. An additional 1 to 2% of the dose is 
recovered from the bile in the form of metabolites. Approximately 20 to 35% of an 
oral dose is recovered from the faeces within 5 days after dosing. This may arise 
from either biliary clearance or transintestinal elimination (36). 
2.7.4 Microbiology 
CIP has in vitro activity against a wide range of gram-negative and gram-positive 
microorganisms. The mechanism of action of FQs, including CIP, is different from 
that of penicillins, cephalosporins, aminoglycosides, macrolides, and tetracyclines; 
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therefore, microorganisms resistant to these classes of drugs may be susceptible to 
CIP and other Qs. There is no known cross-resistance between CIP and other 
classes of antimicrobials. In vitro resistance to CIP develops slowly by multiple step 
mutations. 
CIP is slightly less active when tested at acidic pH. The inoculum size has little effect 
when tested in vitro. The minimal bactericidal concentration (MBC) generally does 
not exceed the minimal inhibitory concentration (MIC) by more than a factor of 2 (36). 
 2.7.5 Indications and Usage 
 I. Adult Patients: 
Urinary Tract Infections caused by Escherichia coli, Klebsiella pneumoniae, 
Enterobacter cloacae, Serratia marcescens, Proteus mirabilis, Providencia rettgeri, 
Morganella morganii, Citrobacter diversus, Citrobacter freundii, Pseudomonas 
aeruginosa, methicillin-susceptible Staphylococcus epidermidis, Staphylococcus 
saprophyticus, or Enterococcus faecalis. 
Acute Uncomplicated Cystitis in females caused by Escherichia coli or 
Staphylococcus saprophyticus. 
Chronic bacterial prostatitis caused by Escherichia coli or Proteus mirabilis. 
Lower Respiratory Tract Infections caused by Escherichia coli, Klebsiella 
pneumoniae, Enterobacter cloacae, Proteus mirabilis, Pseudomonas aeruginosa, 
Haemophilus influenzae, Haemophilus parainfluenzae, or penicillin-susceptible 
Streptococcus pneumoniae. Also, Moraxella catarrhalis for the treatment of acute 
exacerbations of chronic bronchitis. 
Acute sinusitis caused by Haemophilus influenzae, penicillin-susceptible 
Streptococcus pneumoniae, or Moraxella catarrhalis. 
Skin and Skin Structure Infections caused by Escherichia coli, Klebsiella 
pneumoniae, Enterobacter cloacae, Proteus mirabilis, Proteus vulgaris, Providencia 
stuartii, Morganella morganii, Citrobacter freundii, Pseudomonas aeruginosa, 
methicillin-susceptible Staphylococcus aureus methicillin-susceptible Staphylococcus 
epidermidis, or Streptococcus pyogenes. 
Bone and joint infections caused by Enterobacter cloacae, Serratia marcescens, or 
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Pseudomonas aeruginosa. 
Complicated intra-abdominal infections (used in combination with metronidazole) 
caused by Escherichia coli, Pseudomonas aeruginosa, Proteus mirabilis, Klebsiella 
pneumoniae, or Bacteroides fragilis. 
Infectious Diarrhea caused by Escherichia coli (enterotoxigenic strains), 
Campylobacter jejuni, Shigella boydii†,Shigella dysenteriae, Shigella flexneri or 
Shigella sonnei† when antibacterial therapy is indicated. 
Typhoid fever (Enteric fever) caused by Salmonella typhi. 
Uncomplicated cervical and urethral gonorrhea due to Neisseria gonorrhoeae. 
 II. Pediatric patients (1 to 17 years of age): 
Complicated urinary tract Infections and pyelonephritis due to Escherichia coli. 
 Adult and Pediatric Patients: 
Inhalational anthrax (post-exposure): To reduce the incidence or progression of 
disease following exposure to aerosolized Bacillus anthracis. 
Ciprofloxacin serum concentrations achieved in humans served as a surrogate 
endpoint reasonably likely to predict clinical benefit and provided the initial basis for 
approval of this indication.4 Supportive clinical information for Cip for anthrax post-
exposure prophylaxis was obtained during the anthrax bioterror attacks of October 
2001 (36). 
2.7.6 Biodegradability 
CIP was not biodegradable in the CBT (37). CIP was found in concentrations 
between 0.7 and 124.5 lg/l in efluents from hospitals and was assumed to be the 
main source of genotoxic effects measured with the umuC test in hospital efluents 
(38). Additionally, resistant bacteria may be selected by antibiotic substances in the 
aeration tanks or anaerobic digestion process of STPs (33). 
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2.8 NORFLOXACIN 
 
Fig.4. Norfloxacin 
1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1H-quinoline- 3-carboxylic acid 
 
 2.8.1 Absorption 
NOR is rapidly absorbed; 30% to 40% absorbed in fasting patients. Food and dairy 
products decrease absorption. Steady state is two days, Cmax is 0.8 to 2.4 mcg/mL, 
and Tmax is approximately 1 h after dosing. 
 2.8.2 Distribution 
Protein binding is 10% to 15% and crosses the placenta. 
 2.8.3 Metabolism 
Suggested as first-pass metabolism; however, further study is needed. 
 2.8.4 Elimination 
NOR is eliminated in urine (26% to 32% as NOR, 5% to 8% as active metabolites) 
and feces (30%). 
 2.8.5 Indications and Usage 
Oral treatment of urinary tract infections caused by susceptible organisms, treatment 
of STDs caused by Neisseria gonorrhoeae ; ocular solution for treatment of 
superficial ocular infections due to strains of susceptible organisms; prostatitis 
caused by E. coli (39). 
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CIP and NOR are the two most consumed FQs in human medicine. Therefore, their 
presence in sewage sludge may be notorious due to their strong adsorption 
properties. This hypothesis is in concordance with the data reported by Golet et al., 
according to which the extent of elimination for FQs during municipal wastewater 
treatment would be in the range of 79–87%. An study conducted in several municipal 
wastewater treatment plants in Switzerland reveals that the concentrations of the two 
FQs in raw sewage sludge were in the range 1.4–2.03 mg/kg, being in the same 
range as those found in digested sludge, 2.13–2.42 mg/kg. This high concentration 
level indicates their high affinity towards solid phases, as sludge can be in a 
wastewater treatment process (40). 
 
2.9. MONITORING OF FQS 
Analysis of FQs for the drug monitoring in human serum or urine and the 
determination in aqueous samples have been carried out mainly by high-
performance liquid chromatography (HPLC) with UV and fluorescence detector (FD), 
liquid chromatography/mass spectrometry (LC/MS), or LC–tandem mass 
spectrometry (LC/MS/MS). These methods are coupled with off-line or on-line solid-
phase extraction (SPE) techniques for extraction and concentration of FQs in 
environmental water samples. Most of these techniques, however, require large 
sample volumes. The in-tube solid-phase microextracation (SPME) technique, using 
an open tubular fused-silica capillary with an inner surface coating as extraction 
device, is simple and can be easily coupled on-line with HPLC, LC/MS and 
LC/MS/MS (30). 
2.9.1 High-performance liquid chromatography (HPLC)  
Samples were analyzed by HPLC with fluorescence detector. HPLC instruments 
consist of reservoir of mobile phase, a pump, an injector, a separation column and 
detector. Compounds are separated by injecting a plug of the sample mixture onto 
into the column. The different compounds in the mixture pass through the column at 
different rates due to differences in their partitioning behaviour between the mobile 
liquid phase and stationary phase (41). 
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2.9.2 Fluorescence detector 
Fluorescence detector is used almost exclusively in liquid chromatography and is a 
specific detector that senses only those substances that fluoresce. A flow cell is used 
as the sensor through which the excitation light passes axially. A photocell is situated 
at the side of the cell to receive radialy emitted light. The cell wall is often made of 
Pyrex glass to prevent the excitation light (usually UV light) from reaching the photo 
cell. When a solute that fluoresces in the excitation light is situated in the cell, the 
fluorescent light passes through the walls of the cell onto the photo cell, the output of 
which is electronically processed and the output passed to a computer. The 
excitation light may be UV at 254 nm produced by the mercury lamp or it may be light 
of any wavelength selected from the light produced by a deuterium lamp using a 
monochromator. A monochromator may also be used to analyze the fluorescent light 
and, thus a fluorescent spectrum can be produced for excitation light of any specific 
wavelength and an excitation spectrum produced for fluorescent light of any specific 
wavelength. To improve the specificity of an LC analysis, a fluorescent derivative of 
the substance of interest may be prepared (employing an appropriate fluorescent 
reagent). The substance may then be selectively detected from other solutes which, 
(if they do not fluoresce) need not be resolved from each other by the 
chromatographic column (42). 
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AIM 
 
The aim of this work was the development and validation of an analytical 
methodology, sensitive, accurate and precise for determination of three 
fluoroquinolones (norfloxacin, ciprofloxacin and enrofloxacin) in wastewater and 
surface samples in an intensive piggery.  
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3. EXPERIMENTAL PART 
3.1 REAGENTS AND MATERIALS 
Standards of norfloxacin, ciprofloxacin and enrofloxacin were purchased from Sigma-
Aldrich (Steinheim, Germany). Methanol and acetonitrile HPLC grade, and fosforic 
acid RPE-ACS were purchased from Carlo Erba (Milan, Italy). Sulphuric acid 95-97% 
“Baker Analyzed” (Deventer, Netherlands), tetrabuthylammonium and disodium 
ethylenediaminetetraacetate (Sigma-Aldrich, Steinheim, Germany). Water was 
purified by distillation and passage through Milli Q system (Millipore, Bedford, MA), 
EDTA (Merck, Germany). 
Extraction cartridges Oasis HLB 6cc/ 200 mg (Waters Corp. Milford, MA). 
 
3.2 EQUIPMENT 
The HPLC method described here was developed using a HPLC system, consisting 
of two pumps (model 307, Gilson Medical Electronics, France), a injector Model 7125 
(Rheodyne, Cotati, California, USA), a column oven (Technology, LDA), a 
Fluorimeter detector (LabAlliance, France) operated at an excitation wavelength of 
278 nm and an emission wavelength of 450 nm. The spectral bandwidth was 10 nm 
for both excitation and emission. The results were recorded on a SP 4270 integrator 
(Hewlett Packard, Philadelphia, USA). NOR, CIP and ENRO were eluted isocratically 
using a mobile phase consisting of 0.025 M Phosphoric acid and Methanol (90:10) 
through a monolithic (Chromolith Performance RP-18e (100 x 4.6 mm) from Merck, 
Darmstand, Germany). The HPLC system was operated at room temperature and 
the flow rate was 2.2 mL/min. 
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3.3 ANALYTICAL METHODOLOGY 
3.3.1 Sampling and storage of samples 
Samples were collect from wastewaters and surface waters in an intensive piggery 
and transported at low-temperature. Samples were storage at 4°C in dark. 
Sampling: 
1. Waste lagoon primary 
2. Waste lagoon secondary 
3. Waste lagoon tertiary 
4. Wastewater 
5. Receiving piggery effluent 1 
6. Receiving piggery effluent 2 
7. Water river receiving piggery effluent 1 
8. Water river receiving piggery effluent 2 
 
3.3.2 Preparation of mobile phase 
The mobile phase used for the analysis was consisting of 0.025 M phosphoric acid 
solution (adjusted to pH 3 with tetrabutylamonium) and methanol (90:10). It was 
filtered through a 0.45µm filter under vacuum and degassed by ultrasonication. 
 
3.3.3 Preparation of standard fluoroquinolones solutions 
Individual stock standard solutions (1 mg/mL) of the three fluoroquinolones were 
prepared by dissolving of standards in 0.005 M Sulphuric acid (0,025g of standard 
was dissolved in 25mL of sulphuric acid).  
The working standard solutions (at concentration level 0.1µg/mL, 0.25µg/mL, 
0.5µg/mL, 1µg/mL) were prepared by a serial dilution of the stock standard solutions 
in 0.005 M sulphuric acid. The volume of prepared working standard solutions was 
10mL. Used volume of stock standard solution is shown in table 1. 
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Concentration of 
working solution 
(µg/mL) 
Volume of stock 
solution (µL) 
0.1 1 
0.25 2.5 
0.5 5 
1 10 
Table 1. Preparation of standard FQs solutions 
 
3.3.4 Preparation of samples 
The extractions were performed using Solid Phase Extraction (SPE) cartridges 
(Waters Oasis HLB, 200mg, 6 cc cartridge). The cartridge was conditioned with 5 mL 
of methanol and 5 mL of Citric acid 0.04M. The water samples were filtered through 
membrane filter (polyamid 0.2µm, NL 16 Schleicher and Schuell) and adjust to pH 4 
with Sulphuric acid (1 M). Then 200mg of EDTA di-potassium salt was added. 50mL 
of the sample was percolated through the cartridge. Washing was performed by 5mL 
of Citric acid and 5ml of Milli-Q water at pH 4.2. Then the cartridge was eluted with 
4mL of methanol. This eluate was evaporated to dryness in a water bath (40°C) 
under a gentle stream of nitrogen and the residue was redissolved in 0.5mL of mobile 
phase. Then final filtration through membrane filter 0.45µm was done. A volume of 
50µl (respectively 20µl of samples 6-8) was injected for analysis. 
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4. RESULTS AND DISCUSSION 
4.1 VALIDATION OF ANALYTICAL METHODOLOGY 
     Method validation is one of the measures universally recognized as a necessary 
part of a comprehensive system of quality assurance in analytical chemistry. Reliable 
analytical methods are required for compliance with national and international 
regulations in all areas of analysis providing data of the required quality. 
     Analytical method validation is completed to ensure that an analytical 
methodology is accurate, specific, precise and robust over the specified range that 
an analyte will be analysed. 
     The main aim of validation of an analytical method is to perform that the method is 
suitable for its intended purpose, such as implementation of legislation and for 
monitoring and risk assessment studies. It must be ensured that the method 
generates meaningful data and is accurate, specific, reproducible and robust over the 
specified range that an analyte will be analysed.  
 
4.2 RETENTION TIME OF FQs 
A volume of injection of 50µL of the standard solutions of NOR, CIP, ENRO at 
concentration 0.25µL were injected three times each day during consecutive three 
days, to evaluate intraday and interday precision. 
 The mean retention times and the precision value of the retention times are shown in 
table 2. 
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RT (min) 
intraday 
RSD (%) 
interday 
RSD (%) 
NOR 4.91 7 13 
CIP 5.62 6 11 
ENRO 8.00 9 17 
                   Table 2. Retention times of Nor, Cip, Enro 
 
Using the monolithic column in HPLC, the time of analysis can be decreased. In our 
case, all three fluoroquinolones were separated in about 8 minutes. The relatively 
high RSDs are due to the instability of the HPLC system used. 
4.3 LINEARITY AND RANGE 
The calibration curve was prepared by measurement of areas of FQs standard 
solutions in the range from 0.1 to 1µg/mL. Each level of concentration was injected 
three times. 
The linearity of the method was obtained by using the linear least squares regression 
procedure of the peak area versus concentration. The linearity for FQs, in the 
working standard solutions of four concentrations levels, was good as shown the fact 
that the determination of mean correlation coefficients (R) were higher than 0.998 for 
all of them (Fig. 2-4). 
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4.4 SPECIFITY  
In order to verify the absence of potential interfering substances around the retention 
time of OTA, water blanks were analyzed in order to assess the specificity of the 
method. No interferences were observed in the region of interest. 
 
 
4.5 CALIBRATION CURVES 
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4.5.1 Norfloxacin 
Fig. 2. : Calibration curve of NOR 
 
 
4.5.2 Ciprofloxacin 
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Fig.3. : Calibration curve of CIP 
 
4.5.3 Enrofloxacin 
Fig. 4. : Calibration curve of Enrofloxacin 
4.6 RECOVERY ASSAYS 
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Fortified samples were prepared by same method like common sample but before 
SPE was an accurate amount of standard solutions (NOR, CIP, ENRO) added  into 
50ml of blank water sample. The accuracy of the method was studied by spiking 
water samples at three fortification levels: 0.2, 0.02, 0.01µg/mL. Extraction efficiency 
was determined by comparison of the peak areas obtained from fortified samples 
with those given by standard solutions. 
Within-day accuracy and precision data were determined by analysing, on the same 
day, three replicates of a spiked sample at three fortification levels, and one blank (to 
check for interferences). The between-day accuracy and precision were also 
determined by extracting batches of three fortification levels and analysing them on 
three consecutive days.  
 The recovery values ranged from 66.9% to 98.7% for NOR, from 99 %to 114% for 
CIP and from 66.4% to110% to ENRO. The average recovery was 89.5%. Value of 
inter and intra-day RSD were less than 19%. 
              
 
4.7 CONCENTRATIONS OF FQS IN SAMPLES 
 
A total eight samples of wastewaters and surface waters were analyzed under the 
conditions described and concentration of FQs in samples were calculated by 
comparing the peak areas of the samples and of the standards.  Fig. 5 shows 
chromatogram of standard solution containing 0.25µg/mL of NOR, CIP and ENRO. 
Fig. 6 gives example of chromatogram of waste lagoon tertiary sample. 
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Fig. 5.: Chromatogram of standard mixture of 0.25µg/mL of NOR, CIP, ENRO 
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Fig. 6.: Cromatogram of waste lagoon tertiary sapmle 
Each sample was injected three times and the results obtained are presented: 
 
1.  Waste lagoon primary- NOR was detected at concentration of 0.6ng/ml, CIP 
0.45ng/ml and ENRO 0.71ng/ml. 
2. Waste lagoon secondary - NOR 0.28ng/ml. 
3. Waste lagoon tertiary 
4. Wastewater – NOR 4.4ng/ml, CIP 1.8ng/ml and ENRO 0.92ng/ml. 
5. Receiving piggery effluent-  NOR113.6ng/ml, CIP 15.2ng/ml, ENRO 2.28ng/ml.  
6. Receiving piggery effluent 2- NOR 12.35ng/ml, ENRO  2.33ng/ml. 
7.Water river receiving piggery effluent 1 
8. Water river receiving piggery effluent 2 
 
Samples were collected from one intensive piggery, to assess the frequency of 
occurrence in detectable concentrations and to some extent, fate of the monitored 
antibiotics. Leaching experiments are a part of environmental risk assessment (ERA) 
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to estimate the distribution and fate of these antibiotics in the environment. 
Therefore, a study on migration of antibiotic residues in the surround environment 
was undertaken. Wastewaters, superficial water immediately proximal to the piggery, 
collected during sampling period were analyzed.  
NOR was detected in 4 samples, at concentrations between 0.28 µg/L and 13.6 µg/L, 
ENRO was found in three samples in a range between 0.92 µg/L and 2.33 µg/L and 
CIP, its degradation product, was presented in two samples between 1.8 µg/L and 
15.2 µg/L. CIP detection is explained by N-dealkylation of ENRO. 
In a study on migration of antibiotic residues in the surround environment, we noted 
the occurrence of FQs residues in waste lagoon (primary and secondary), in 
wastewater and in receiving piggeries effluents. 
 
 
 
5. CONCLUSION 
An HPLC with fluorometric detection was tested for determination of NOR, CIP, 
ENRO in wastewater and surface waters from piggery.  
The best result was achieved by using mobile phase consist of Phosphoric acid 
0.025M and methanol (90:10 v/v), flow rate 2.2mL/min, excitation wavelengths of 278 
and emission wavelengths of 450 nm.  
We tested the linearity of the calibration curves for concentration ranges that are 
normally measured in waste water. The correlation coefficient were higher than 0.998 
for each of he compound of interest. 
The instrumental repeatability and precision were assessed by repeated injection of 
standard mixtures. The values of inter and intra-day RSD were less than 17%. 
LOQs expressed as the lowest tested level with acceptable RSD was 25 ng/L. 
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The prevalence of antimicrobials compounds in water samples proximal to swine 
farms, coupled with the results from the animal waste samples, provide evidence that 
animal waste stored in lagoons or applied to agricultural fields as fertilizer appears to 
act as a non-point source of antimicrobial residues in water sources. 
Concluding from the experimental data, the concentration of FQs was highest for 
samples collected in waste lagoons (primary and secondary), wastewater and 
receiving piggery effluents. 
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7. ABBREVIATIONS 
 
FQs Fluoroquinolone antibiotics 
NOR Norfloxacin 
CIP Ciprofloxacin 
ENRO Enrofloxacin 
LC Liquid chromatography 
FD Fluorescence detector 
LQs Limits of quantification 
RSD Relative standard deviation  
STP Sewage treatment plant 
WWTPs Wastewater treatment plants 
PPCPs Pharmaceuticals and personal care products 
Kd, solid Sorption coefficient 
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Koc Organic carbon-normalized sorption coefficient 
Qs Quinolone antibiotics 
FLE Fleroxacin 
NAL Nalidixic Acid 
FLU Flumequine  
OXO Oxolinic acid 
ROS Reactive oxygen species 
LOM Lomefloxacin 
CBT Closed bottle test 
OFLO Ofloxacin 
ENRO Enrofloxacin 
CSF Cerebrospinal fluid 
MBC Minimal bactericidal concentration 
MIC Minimal inhibitory concentration 
 
 
 
 
SOUHRN 
Znalost koncentrace léčiv v životním prostredí je velice důležitá. Hlavním důvodem je 
to, že jsou to látky s účinkem na živý organismus a jejich fyzikálně- chemické 
vlastnosti jsou často podobné škodlivým xenobiotikům. 
Antibiotika patří mezi nejčastěji předepisovaná léčiva. Fluorochinolonová antibiotika 
jsou používána k terapii i k profylaxi lidských i zvířecích onemocnění. Především k 
léčbě širokého spektra respiračních a enterických infekcí a infekcí močových cest. 
Kromě toho jsou také v subterapeutický dávkých užívány ke stimulaci růstu 
hospodářských zvířat. 
Podstatou účinku fluorochinolonů je inhibice DNA-gyrazy. Jsou účinné proti gram-
negativním i gram-pozitivním bakteriím. 
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Účinek fluorochinolonů je závislý na jejich chemické struktuře, nezbytná je přítomnost 
volné karboxylové skupiny v poloze 3 a oxoskupiny v poloze 4. Prostřednictvím 
těchto skupin dochází k vazbě na DNA-gyrázu. Karboxylová skupina a amino 
skupina určují jejich acidobazické vlastnosti. Jejich aktivita je tedy také významně 
závislá na pH prostředí. 
25-75% podaných antibiotik je z organismu vyloučeno v nezměněné formě. 
Metabolismem vznikají sloučeniny, které mohou být méně nebo více učinné než 
původní látka. 
Část těchto sloučenin je odstraněno v čistírnách odpadních vod. Určitý podíl  ale ve 
vodě zůstává. Tak se fluorochinolony přítomné v odpadních vodách z nemocnic, 
domácností a vznikajících vlivem zemědělství, včetně prasečích farem, mohou 
odtokem dostat do povrchových vod. 
Flurochinolony jsou poměrně odolné mikrobiální degradaci a díky sorpci pak mohou 
setrvávat v životním prostředí, především ve splaškovém kalu, v hnojivu a v půdě.  
Rozsah sorpce a degradace je určen především fyzikálně chemickými vlastnostmi 
sloučenin jako jsou tvar a velikost molekuly, rozpustnost a lipofilita. Záleží také na 
kvalitě výroby, geografické poloze a klimatických podmínkách. 
Tyto rezidua pak mohou negativně ovlivnit živé organismy a to na každé úrovni tzn. 
buňky, orgánu, organismu, populace, ekosystemu i celé ekosféry. 
Nebezpečí vyplývá z jejich přímé toxicity na mikroorganismy, které jsou nezbytné pro 
proces čistění vody, ale také pro uzavření potravního řetězce a vzniku organických 
látek. 
Antibiotika také mohou vyvolat u lidí alergické reakce. 
Užívání těchto antibiotik je ale také spojeno s rozvojem rezistence u bakterií. Chov 
vepřů je považován za významný zdroj rozvoje antibakteriální rezistence a proto byly 
v posledních letech přijata různá kontrolní opatření pro používání antibiotik v chovu 
dobytka. 
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Cílem této práce bylo dopracovat a validovat přesnou a citlivou metodu pro stanovení 
fluorochinolonů v odpadních a povrchových vodách v oblasti intenzivního chovu 
vepřů v Portugalsku. 
Ke stanovení norflofacinu (NOR), ciprofloxacinu (CIP) a enrofloxacinu (ENRO) byla 
použita úspěšně vyvinutá LC-FD metoda (4) založená na použití monolitické kolony 
(Chromolith Performance RP-18e (100 x 4.6 mm). Flurochinolony byly izokraticky 
eluovány mobilní fází tvořenou 0,025M roztokem kyseliny fosforečné o pH 3 
(dosaženo tertabutyamoniem) a methanolem (90:10 v/v). Objemový průtok byl 2,2 
ml/min, hodnota excitační vlnové délky byla 278nm, emisní vlnová délka byla 450nm. 
Vzorky byly odebrány z odpadních a povrchových vod v oblasti intenzivního chovu 
vepřů. Do použití byly uchovávány v temnu v teplotě do 4ºC. 
Nejprve byly zjištěny retenční časy pro standardy. Pro NOR 4,91min, CIP 5,62 min, 
ENRO 8,00 min. 
Úprava vzorků byla provedena metodou SPE (extrakce pevným sorbentem). SPE 
kolonky byly nejprve promyty 5ml methanolu a 5ml kyseliny citronové. Poté se 
nechalo perkolovat 50ml vzorku o pH 4, do kterého bylo přidáno 200mg didraselné 
soli EDTA. Poté se kolonka promyla 5ml kyseliny citronové a 5ml Milli-Q vody o pH 
4.2. Eluce byla provedena 4ml methanolu. Tento eluát se nechal odpařit ve vodní 
lázni pod slabým proudem dusíku a znovu rozpustil v 0,5 ml mobilní fáze. 
Následovala závěrečná filtrace. 
Pomocí roztoků standardů o koncentraci 0,1- 1µg/ml byly sestaveny kalibrační křivky 
závislosti plochy píku na koncentraci. Hodnota lineárního korelačního koeficientu (R) 
byla ve všech třech případech vyšší než 0,998. 
Mez stanovitelnosti byla 25ng/L. Výtěžek (recovery) metody je v rozmezí 66,4- 114%. 
Hodnota správnosti a přesnosti měření (vyjádřena jako relativní směrodatná 
odchylka) byla nižší než 17%. 
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Nor byl zjištěn ve 4 vzorcích v koncentraci 0,28µg/ml- 13,6µg/ml, Enro ve 3 vzorcích 
v koncentraci 0,92µg/ml- 2,33µg/ml, Cip ve 2 vzorcích v koncentraci 1,8µg/ml- 
15,2µg/ml. Přítomnost Cip je vysvětlována N-dealkylací Enro. 
